These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2086420)

  • 1. [Local carbonic anhydrase inhibitors MK-927 and Mk-417. Effect and tolerance].
    Gerling J; Pfeiffer N; Lippa E; Brunner-Ferber F; Grehn F
    Fortschr Ophthalmol; 1990; 87(6):692-5. PubMed ID: 2086420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N; Grehn F; Hennekes R; Garus H
    Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417.
    Pfeiffer N; Gerling J; Lippa EA; Brunner-Ferber FL; Panebianco D; Grehn F
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):111-4. PubMed ID: 2044968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stereospecificity of lowering intraocular pressure using a locally administered carbonic anhydrase inhibitor].
    Diestelhorst M; Bechetoille A; Lippa E; Brunner-Ferber F; Krieglstein GK
    Fortschr Ophthalmol; 1990; 87(2):131-3. PubMed ID: 2358266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MK-507 (L-671 152): local tolerance and effectiveness of a new local carbonic anhydrase inhibitor in healthy probands].
    Hofmann HM; Feicht B; Brunner-Ferber E; Lippa E; von Denffer H
    Fortschr Ophthalmol; 1991; 88(5):513-4. PubMed ID: 1757042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands].
    Feicht B; Hofmann HM; Lippa E; Brunner-Ferber F; von Denffer H; Merté HJ
    Klin Monbl Augenheilkd; 1990 Sep; 197(3):254-7. PubMed ID: 2255169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor.
    Lippa EA; von Denffer HA; Hofmann HM; Brunner-Ferber FL
    Arch Ophthalmol; 1988 Dec; 106(12):1694-6. PubMed ID: 3058101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy.
    Hiett JA; Dockter CA
    Optom Clin; 1992; 2(4):97-112. PubMed ID: 1286242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC; Gum GG; Gelatt KN
    Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful pressure decrease and improved patient quality of life by Trusopt].
    Prell R
    Klin Monbl Augenheilkd; 1996 Apr; 208(4):11-2. PubMed ID: 8778487
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local carbonic anhydrase inhibitor dorzolamide: development and properties].
    Pfeiffer N
    Ophthalmologe; 1996 Feb; 93(1):103-18. PubMed ID: 8867167
    [No Abstract]   [Full Text] [Related]  

  • 12. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E; Stefánsson E; Bjarnadóttir G; Sigurjónsdóttir JF; Gudmundsdóttir G; Masson M; Loftsson T
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R; Ticho U
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the European Glaucoma Prevention Study.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
    Yamazaki Y; Miyamoto S; Sawa M
    Jpn J Ophthalmol; 1994; 38(1):92-6. PubMed ID: 7933704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
    Fanous MM; Challa P; Maren TH
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.
    Pfeiffer N; Hennekes R; Lippa EA; Grehn F; Garus H; Brunner-Ferber FL
    Br J Ophthalmol; 1990 Jul; 74(7):405-8. PubMed ID: 2198931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trusopt, a topical carbonic anhydrase inhibitor.
    Donohue EK; Wilensky JT
    J Glaucoma; 1996 Feb; 5(1):68-74. PubMed ID: 8795737
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.